About clot management devices
A blood clot or thrombus is the end stage of blood coagulation process in hemostasis. Blood clot is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormally to obstruct blood flow through healthy blood vessels. This condition is called thrombosis. A blood clot in arteries can lead to heart attack, while blood clot formed in the deep veins can lead to DVT or PE. Clot management devices help in the removal of a clot or dissolving clot in the blood vessels.
TechNavio's analysts forecast the global clot management devices market to grow at a CAGR of 5.95 percent over the period 2014-2019.
Covered in this report
The report covers the present scenario and the growth prospects of the global clot management devices market for the period 2015-2019. Based on type of devices, the market can be segmented as follows: percutaneous thrombectomy devices, embolectomy balloon catheters, catheter-directed thrombolysis, IVCF, and neurovascular embolectomy devices.
TechNavio's report, the Global Clot Management Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global clot management devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Global Clot Management Devices Market 2015-2019
Technavio recognizes the following companies as the key players in Global Clot Management Devices Market 2015-2019: AngioDynamics Inc, Boston Scientific Corp, Cook Medical and Stryker Corp.
Other Prominent Vendors in the market are: Arion Laboratories, Establishment Labs, GROUPE SEBBIN, Guangzhou Wanhe Plastic Materials, Hans Biomed, CEREPLAS Ideal Implant, Silimed and POLYTECH Health & Aesthetics
Commenting on the report, an analyst from Technavio’s team said: “One of the trends is the increased number of MIS procedures. Surgical procedures expose a patient’s blood to foreign surfaces, which may initiate coagulation. DVT and PE are some major complications faced by patients who undergo surgery. MIS reduces patient trauma and recovery time.”
According to the report, a rise in awareness of endovascular treatment is one of the primary drivers in this market. Endovascular treatment is a surgical treatment in which microcatheters, embolic coils, and stents are used to remove blood clots.
Further, the report states that the high acceptance of anticoagulant therapy is hindering the growth of the market.
AngioDynamics Inc, Boston Scientific Corp, Cook Medical, Stryker Corp., Acandis GmbH & Co. KG, Argon Medical Devices, Asid Bonz, Biosensors International Group, Control Medical Technology, Covidien, DePuy Synthes, Dispomedica, Edwards Lifesciences, EKOS, a BTG International group company, Eurocor, FBMedical-ISOMed, iVascular, LeMaitre Vascular, Merit Medical Systems, Phenox GmbH, Straub Medical AG, Teleflex